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Pancreatic islets play an essential role in regulating blood glucose level. Although the
molecular pathways underlying islet cell differentiation are beginning to be resolved, the
cellular basis of islet morphogenesis and fate allocation remain unclear. By combining
unbiased and targeted lineage tracing, we address the events leading to islet formation in the
mouse. From the statistical analysis of clones induced at multiple embryonic timepoints, here
we show that, during the secondary transition, islet formation involves the aggregation of
multiple equipotent endocrine progenitors that transition from a phase of stochastic ampli-
fication by cell division into a phase of sublineage restriction and limited islet fission.
Together, these results explain quantitatively the heterogeneous size distribution and degree
of polyclonality of maturing islets, as well as dispersion of progenitors within and between
islets. Further, our results show that, during the secondary transition, α- and β-cells are
generated in a contemporary manner. Together, these findings provide insight into the cel-
lular basis of islet development.
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Hormone secretion by the islets of Langerhans in thepancreas regulates blood glucose level, while abnormalislet function leads to diabetes mellitus1. Mature islets in
mice are comprised predominantly of an external mantle of
glucagon producing α-cells and an internal core of insulin pro-
ducing β-cells. They also contain minority populations of cells
secreting other pancreatic hormones such as somatostatin,
ghrelin and Polypeptide P (Fig. 1a). Based on their central role in
regulating glucose homoeostasis, much emphasis in pancreas
biology has been placed on resolving the signalling pathways
involved in the generation of β-cells during development2,3, and
their maintenance in adulthood4,5.
Previously, we and others have shown that, following an early
phase of plexus remodelling, the large-scale organisation of
mouse pancreas involves an extended phase of ductal branching
morphogenesis, driven by minority subpopulations of sublineage-
restricted, self-renewing progenitors that localise at the termini of
ducts6–8. One population drives rounds of ductal bifurcation,
giving rise to unipotent (ductal) and bipotent (ductal–islet) pro-
genitors, while a second population of acinar-committed pro-
genitors travels with cells at the ductal termini, replicating during
tip bifurcation and finally differentiating into acinar cells6. Fol-
lowing commitment to the islet lineage, progenitors egress from
the ductal epithelium9. It has been proposed that the central
plexus, which remodels during embryonic development, may
provide a niche for endocrine cell differentiation, with robust,
non-autonomous and long-lived production of islet progenitors
occurring until late embryogenesis7. A lineage tracing study has
shown that progenitors with an active promoter of Neurogenin3
(Ngn3), the basic helix–loop–helix (bHLH) transcription factor
and master regulator of endocrine differentiation, are restricted to
islet sublineages, and undergo few rounds of division between
birth and adulthood10, with further compensatory replication and
maturation acquired after weaning11. However, the timing,
potency and growth potential of individual islet progenitors
during normal embryonic development remains poorly defined.
Based on lineage tracing and gene knock out studies, it is known
that islets arise from cells in maturing embryonic pancreatic ducts
that express Ngn312–15. Individual islets in the adult pancreas are
also known to be polyclonal in origin16. Recently, transcriptomic
analyses and 3D imaging of the embryonic day (E)13.5–E14.5
pancreas suggested that a temporally graded differentiation of
Ngn3+ progenitors, occurring first into the α and then the β-cell
sublineage, could explain the mantle–core structure of mature
islets17. However, whether this temporal gradient in α- and β-cell
production persists during later stages of development remains
unclear. It is also unclear whether fate allocation to the endocrine
lineage and its sublineages occur stochastically and where, spatially,
commitment occurs. Finally, in adult, both mouse and human islets
are found to be highly heterogeneous in size, with variations of up
to a thousandfold in volume18,19. While islet fusion and fission
processes have been suggested to underlie this heterogeneity18,19,
their cellular and mechanistic basis remain unknown.
Here, we combine unbiased and targeted genetic lineage tra-
cing strategies using mouse models based on a Rosa26 (R26) and
Ngn3 promoter, respectively, with three-dimensional confocal
imaging and mathematical modelling to address cell fate beha-
viour, sublineage restriction and spatial patterning during islet
morphogenesis in the mouse pancreas. In particular, we show
that, during the secondary transition, islet formation involves the
aggregation of multiple equipotent endocrine progenitors that
expand by stochastic proliferation after which they enter a phase
of sublineage restriction and limited islet fission. Together, these
findings provide a quantitative explanation for the heterogeneous
size distribution and degree of polyclonality of maturing islets, as
well as dispersion of clones within and between islets.
Results
Unbiased lineage tracing of islet progenitors. To address the
dynamics of islet development, we used the R26-CreERT2/R26R-
Confetti mouse model to trace the fate of progenitors in the
embryonic pancreas. Using the R26R-Confetti mouse line, four
fluorescent reporter genes (GFP, YFP, RFP and CFP) can be
expressed at random after Cre‐mediated recombination, provid-
ing a hereditary mark that records the fate of induced cells and
their progenies. By linking Cre expression to the ubiquitous R26
promoter, the labelling strategy is able to activate a fluorescent
reporter in any cell type in an unbiased manner. Recently, we
have used this model to investigate the cellular dynamics
underlying the large-scale spatio-temporal patterning of the
mouse pancreas, with a focus on the specification of the ductal
and acinar compartments6.
To achieve clonal induction, a low dose of Tamoxifen (TAM)
was administered to mice resulting in sparse labelling of tissue
(<3% by volume) at the start of the two key stages of pancreatic
development corresponding to the onset of the primary and
secondary transition20,21; E9.5 and E12.5 (Fig. 1b–d). Based on
the reported time-delay between TAM administration and
induction for Cre-ERT222, cells may be marked up to 24 h post
injection. To target islet development, we quantified the islet cell
content of individual clones at postnatal day (P)14, when
commitment of cells to the pancreatic sublineages is thought to
be complete20, using 3D tissue reconstructions derived from thick
serial sections stained for the islet marker Chromogranin A (with
48 clones reconstructed from n= 3 mice for E9.5 induction and
55 clones from n= 3 mice for E12.5; “Methods”). Notably, we
found that, where clones comprised both islet and ductal cells, the
corresponding islet and duct were in close proximity, consistent
with reports of local egression of endocrine cells16,17.
At the given level of induction, most P14 islets (92% from E9.5
and 82% from E12.5) were comprised exclusively of unlabelled
cells, while the majority of labelled islets contained cells sharing the
same confetti colour (82% and 72% of labelled islets from E9.5 and
E12.5 tracings, respectively) (Fig. 1d and Supplementary Fig. 1).
Such labelling events could arise through the chance induction of
different progenitors that give rise to progenies that occupy the
same islet. Fortunately, by using a confetti labelling system, we
could use measurements of the colour mosaicism of individual
islets to estimate the frequency at which independent clones of the
same colour could arise by chance in the same islet (for details, see
“Methods” Statistical inference of clonality). Accordingly, we found
that, overall, <10% of cell clusters labelled by a common colour in a
given islet were likely to be the result of chance clone merger.
Similarly, we assessed whether an individual labelled progeni-
tor could give rise to progenies that spanned multiple
neighbouring islets at P14. Once again, quantitative analysis of
neighbouring islets bearing cells of a common colour suggested
that the frequency of such events was low, with only 15% of
clones from the E12.5 induction extending across multiple
neighbouring islets compared to 37% from E9.5 (“Methods”
Statistical inference of clonality). It followed that the majority of
labelled cell clusters within individual islets were of clonal origin,
and represent the full islet cell output of an individual tri-, bi- or
unipotent progenitor labelled at E9.5 or E12.5 (Fig. 1e, f and
Supplementary Fig. 1a). (Note that, here, we define a tripotent
islet clone as the islet cell contribution of a clone containing
ductal, acinar and islet cells; a bipotent islet clone as the islet cell
contribution of a clone containing ductal and islet cells, or—
although much rarer—acinar and islet cells; and a unipotent islet
clone as one containing only islet cells.) Based on this assignment,
we then quantified the islet cell number of individual islet clones
(spanning either a single islet or a few neighbouring islets) from
the two induction times.
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Islet progenitors aggregate and proliferate stochastically. When
quantified, we found a large degree of islet clone size variability
(Fig. 1g–i and Supplementary Fig. 1a–j), with some clones con-
taining tens of islet cells while others contained as few as one. We
first considered whether the origin of size variability could derive
from differences in the rate at which progenitors become specified
towards the endocrine lineage. This would be consistent with
reports that, during development, the allocation of islet fate
occurs in a highly asynchronous manner17, so that the net islet
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amplification. We reasoned that, if the source of islet clone size
heterogeneity was associated with late specification towards the
islet lineage, leading to the frequent production of multiple
endocrine progenitors then, for clones containing both ductal and
islet components, the average islet clone size should scale roughly
in proportion to the size of the ductal compartment. If, on the
other hand, separation of the ductal/endocrine lineages occur
early, then islet specification would be a rare event, and the size of
the two compartments in multipotent clones should be statisti-
cally uncorrelated (Fig. 2a).
We therefore examined the correlation between the ductal and
islet compartments within the same clone, combining both
bipotent (ductal–islet) clones and tripotent clones. The compar-
ison failed to reveal significant correlation from either the E12.5
(R2= 0.012, Fig. 2b–e) or E9.5 tracings (R2= 0.06, Supplemen-
tary Fig. 1i). Indeed, further comparison of islet clone size
between unipotent and multipotent clones indicated that the
potential size advantage of the latter was small, and not
statistically significant (P= 0.76 for E12.5 clones, Fig. 2f,
Mann–Whitney test). Together, these results suggest that, for
the majority of islet clones, their size represents the total output of
individual progenitors following commitment to the endocrine
lineage. (Note that, here, we use “commitment” to indicate the
point at which a progenitor becomes fated towards the endocrine
lineage under unperturbed conditions. We cannot rule out the
possibility that, if environmental conditions were no longer
permissive, progenitors could acquire a different fate.)
We then questioned whether the predominant source of size
variability could originate from heterogeneity in the proliferative
activity of progenitors following commitment to the islet lineage
(Fig. 2g). Previous studies have shown that insight into the
potency and fate behaviour of progenitors can be gained from the
distribution of clone sizes23. Strikingly, statistical analysis showed
that the distribution of islet clone size at both induction times was
consistent with an exponential size dependence (Fig. 2h and
Supplementary Fig. 1j, P > 0.2 from a Kolmogorov–Smirnoff test;
“Methods” Theoretical basis for interpreting lineage tracing
datasets). Such behaviour is a hallmark of a single equipotent
population of progenitors undergoing serial rounds of stochastic
cell division24. Here, by stochastic, we mean probabilistic, with
the timings between consecutive cell divisions statistically
uncorrelated, and drawn at random from an exponential
distribution with a given average cell cycle time. Alternative
cellular hierarchies involving, for example, two or more endocrine
progenitor populations would be manifest in the emergence of
more complex, multimodal distributions (see “Methods” Alter-
native models and parameter-fitting). Such behaviour echoes the
results of clonal fate studies of the adult mouse pancreas, which
suggest that islet cells are renewed through stochastic self-
duplication rather than the activity of a minority stem cell-like
pool (Fig. 2g, Supplementary Fig. 1n)25.
We then investigated whether the size of clonally labelled cell
clusters within individual islets were correlated with the total size
of the host islet. We reasoned that, on commitment to the
endocrine lineage, progenitors might harbour the same prolif-
erative potential, but that local factors could cause some
progenitors to proliferate more than others so that large islets
host the largest clonal clusters (Fig. 2i). Yet, despite large
variations in islet size (>30-fold for the ensemble of islets
containing labelled cells), there was little correlation between islet
and clone size, either from E9.5 or E12.5 tracings (R2= 0.001 and
R2= 0.001, respectively; Fig. 2j–l and Supplementary Fig. 1k;
“Methods”). This suggested that the proliferative behaviour of
islet progenitors is not variable between islets, ruling out, for
example, the possibility that large islets arise through locally
enhanced proliferation.
Progressive transition from fusion to fission. We then ques-
tioned the origin of the size heterogeneity of islets themselves.
From the findings above, it follows that variability in islet size is
not derived from coordinated proliferative activity of islet cells.
Instead, it must originate from variations in the net number of
progenitors that associate to form individual islets (Fig. 2m)
(“Methods” Number of progenitors per islet). Quantitatively, we
found that the average fraction f of clonally labelled cells in a
given islet is very small at P14, both from E9.5 (f= 2.7 ± 0.7%,
mean ± SEM) and E12.5 (f= 3.5 ± 0.8%, mean ± SEM) tracings
(Fig. 2n). It followed that the effective number N= 1/f of pro-
genitors that found an islet is around N= 28 ± 6 (mean ± SEM)
on average from the E12.5 tracing and N= 37 ± 10 from E9.5.
This argues that islets develop as highly polyclonal compound
structures (Fig. 2m).
We then questioned whether the spatial organisation of clones
could provide insight into the dynamics of islet formation.
Recently, it has been shown that, following egression, islet
progenitors initially stay associated with ducts17 (Fig. 1a). During
their subsequent expansion, it has been proposed that newly
formed, or nascent, islets may continue to fuse or undergo fission,
influencing the final islet size. Therefore, to probe the dynamics of
islet formation, we focused on the ensemble of “islet doublets” at
P14, where two islets are joined by a narrowing or isthmus
(Fig. 3a, left)26,27. We reasoned that the distribution of clonal
“footprints” on such doublets could discriminate between
putative fission or fusion-type processes27,28, as illustrated by
an analogous study of intestinal crypt fusion/fission29. Specifi-
cally, at clonal density, we reasoned that islet fusion should lead
to events in which, typically, only one portion of a doublet
contains labelled cells; by contrast, following cell dispersion
during islet expansion (Fig. 1e–h), fission should result in the co-
labelling of both portions of a doublet (Fig. 3a, b).
Strikingly, from the analysis of 33 doublets containing labelled
cells from the E12.5–P14 tracings (n= 4 mice), 84% contained
Fig. 1 Lineage tracing reveals broad distribution of islet clone sizes. a Schematic representing pancreas development, from plexus formation, through a
phase of branching morphogenesis and islet formation. Islets are formed by the egression of endocrine progenitors from the ductal epithelium. They
aggregate together to form a mantle–core structure, composed of insulin+ β-cells surrounded by glucagon+ α-cells, as well as cells from other rarer
endocrine lineages. b Schematic representing the experimental schedule, with a single injection of TAM at either E9.5 or E12.5 and tissue collection at P14.
c R26-CreERT2/R26R-Confetti labelling construct. d A 100 μm pancreatic section from R26-CreERT2/R26R-Confetti mice induced at E12.5 and fixed at P14
with islets immunostained by Chromogranin A (grey) and ducts stained by DBA (white) (left panel) showing a low fraction of labelled islets. The
reconstruction (right panel) depicts the corresponding tissue outline, as well as the position of labelled and non-labelled islets. e, f Examples of unipotent
(e) and bipotent (f) clones. For the relative abundances of different clone potencies, see ref. 6. The size of the islet compartment of all the traced clones
were characterised by a wide distribution from g small clones of 1–3 cells to h large clones (≥15 cells). Chromogranin A is shown in grey and DBA in white.
d–h are respectively representative of >15,>20, >20, >20 and 5 recorded images from 3 experiments each. i Sizes of individual islet clones from the E12.5 to
P14 tracings, defined as the total volume of labelled islet cells within individual tri-, bi- and unipotent clones (n= 55 clones from N= 3 mice), showing a
broad distribution. Error bars show average ± SD. Source data provided as Source Data file.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-18837-3
4 NATURE COMMUNICATIONS |         (2020) 11:5037 | https://doi.org/10.1038/s41467-020-18837-3 | www.nature.com/naturecommunications
the same confetti colour in both portions, suggesting that islet
fission predominates over fusion (Fig. 3c). However, as few clones
spanned neighbouring non-doublet islets (15% of E12.5–P14 islet
clones), we deduced that such fission events must be relatively
rare, at least before P14.
To assess the timing of fission events, we examined R26-
CreERT2/R26R-Confetti tracings from E12.5 to E18.5. At E18.5,
islets were arranged in the manner of “beads on a string” in which
nascent islets were associated closely, becoming resolved into
more separated structures only later in development (Fig. 3d, e
and Supplementary Fig. 1m). At this timepoint, we found a lower
percentage of islet doublets with co-labelled portions (50%),
suggesting that fusion is more prominent at earlier stages
(Supplementary Fig. 1l). This result was consistent with the high
degree of islet polyclonality16, and suggested that islet formation
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Fig. 2 Coalescence and stochastic proliferation of islet progenitors underlies islet size heterogeneity. a (Left) Schematic depicting specification of islet
progenitors from bipotent ductal–islet progenitors: If islet progenitor production were a rare event, islet clone size would be independent of ductal clone
size. If the rate were high, islet clone size would scale in approximate proportion to ductal clone size. Representative images from 3 experiments based on
>15 recorded images each showing examples of ductal–islet clones with islet representation being b majority, c minority and d approximately equal.
b, c show snapshots from different Z-sections. Arrows indicate ductal cells, arrowheads indicate islet cells. DBA shown white, Chromogranin A in grey.
e Dot plot of ductal to islet size within individual clones showing weak correlation (R2= 0.012). f Plot of islet size of unipotent (islet-only) and multipotent
clones showing no statistically significant difference in average size (n= 13 unipotent and n= 53 multipotent clones from N= 3 mice, P= 0.76, two-tailed
Mann–Whitney test). Error bars show average ± SD. g Schematic depicting possible modes of islet expansion: (top) endocrine progenitors expand
uniformly within islets; (bottom) progenitors have variable proliferative capacity. h Cumulative distribution of islet clone sizes shows exponential-like
dependence (“Methods”, n= 69 clones from N= 3 mice). Error bars show average ± SD. i Schematic depicting hypothesis that islet size heterogeneity is
associated with local islet-to-islet variability in proliferative activity of constituent progenitors. Representative images (based on >10 recorded images each)
from 3 experiments showing variable labelling fraction within islets with j large clone fraction and k small clone fraction. DBA shown white, Chromogranin
A in grey. l Dot plot showing that there is no correlation between islet clone size and total size of host islet (R2= 0.001). m Summary schematic of islet
growth whereby the final size of islets is dictated by degree of polyclonality arising from coalescence of islet progenitors combined with stochastic
proliferation. Smaller islets are, on average, composed of a smaller number of founding progenitors that merge. n Fraction of islets occupied by individual
islet clones traced from E9.5 to P14 and E12.5 to P14 (n= 93 clones from N= 5 mice at E9.5 and n= 69 clones from N= 3 mice at E12.5). Error bars show
average ± SD. Source data provided as Source Data file.
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subsequent proliferation of islet progenitors is accompanied by
the fusion of nascent islets17, followed by a low rate of fission
during neonatal growth (Fig. 3d, e).
To understand whether there might be an intrinsic size-
dependent mechanism driving islet fission, we investigated the
total size of islet doublets and the size of constituent islets, as well as
single (isolated) islets. While the sizes of single islets vary, the
average size of an islet at P14 and P28 showed no statistically
significant difference (P > 0.1, Mann–Whitney). However, strik-
ingly, the average size of islet doublets was almost double the
average size of single islets, suggesting that fission events are
correlated with islet size. Indeed, if fission occurred randomly in
islets of any size, the overall average size of a doublet undergoing
fission would be the same as the average size of single islets (Fig. 3f).
Stochastic fate allocation of α- and β-cell restriction. So far, we
have focussed on lineage segregation between the ductal and islet
compartments. However, islet cells become further segregated
into sub-compartments: In adult, insulin-producing β-cells
comprise the majority of islet cells in mouse (65–90%), while
glucagon-producing α-cells, which localise on the islet periphery,
make up the other significant compartment (5–20%)30,31. Nota-
bly, this organisation contrasts with human, where islet compo-
sition is more variable with β-cells (30–80%) and α-cells
(10–65%) intermingling in a more “salt-and-pepper”-like
arrangement30,31. Lineage tracing studies using a mosaic analysis
with double-markers (MADM) mouse reporter system based on
constitutive Cre driven from the cis-regulatory regions in a Ngn3-
Cre transgene have argued in favour of early (embryonic) sub-
lineage restriction of islet progenitors into α- and β-cell com-
partments10. However, by the nature of the assay, where the
timing of induction is uncontrolled, the timing of sublineage
restriction is impossible to infer. Further, a study based on the
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Fig. 3 Fission predominates at post-natal stages. a (Left) Schematic of “islet doublets”, defined as nascent islets sharing a common boundary separated
by a narrowing or isthmus. If islet doublets form through islet fusion, islet clones (yellow) are expected to reside in only one portion of the doublet (top
right). If doublets form through fission, islet clones are expected to span both portions (bottom right). b Example images from 3 experiments (based on
>40 recorded images) of putative islet fission events showing the spreading of the clone into both portions of a doublet. Left panel shows staining for
insulin (grey) and glucagon (pink), and right panel shows staining for Chromogranin A (grey) and DBA (white). Arrows indicate constriction between two
doublet islets. c Fraction of all doublets co-labelled by the same confetti colour in each portion (n= 33 islets from N= 3 mice). Error bars show average ±
SD. d 3D projections of Chromogranin A (grey) and DBA (white) stained tissue reveal the evolution of islet structure and location. Small and large islets
indicated with arrows and arrowheads, respectively. Representative of 3 experiments (based on >10 images). e Schematic summarising the key events
during islet formation (cf. panel d). f Quantification of diameters of single and doublet islets as follows: P14—diameter of single islets at P14; P14 islet in
doublet—diameter of constituent islets in a doublet at P14; P14 doublet—diameter of islet doublet; P28—diameter of single islet at P28. For single islets, the
diameter along the longest axis was recorded. For islet doublets, diameters were recorded along the longest axis of the doublet, as indicated in the inset of
the panel (n= 270 islets including 40 doublets from N= 3 mice for P14; n= 71 islets from N= 3 mice for P28). Error bars show average ± SD. Source data
provided as Source Data file.
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transgene construct in Ngn3 knock out mice, has examined the
competency of endocrine cells to form different hormone-
producing cells at different developmental stages32. Here, it was
argued that the competence of pancreatic progenitors to produce
non-glucagon+ cell types is acquired during mid-gestation/later
periods in organogenesis. However, a detailed map of the
dynamics of fate allocation in wild-type animals is still lacking. In
particular, the timing and pattern of sublineage restriction of islet
progenitors remain unclear, as does the relative growth potential
of progenitors pre- and post-sublineage commitment.
To map the potency of islet progenitors, we performed
additional lineage tracings at multiple timepoints (E12.5–P14,
138 clones from n= 4 mice; E15.5–P14, 33 clones from n= 3
mice; and E18.5–P14, 60 clones from n= 3 mice) using the R26-
CreERT2/R26R-Confetti mouse model (Fig. 4a). As with the E12.5
tracing (Fig. 2h), the islet clone size distributions from later
induction times followed an exponential dependence, consistent
with stochastic cell division (“Methods”). To define the
composition of islet clones, we combined staining for glucagon,
insulin and the nuclear marker, DAPI (Fig. 4b–d, Supplementary
Fig. 2 and “Methods”). Cells negative for both insulin and
glucagon were identified, but at such low abundance (<3% in all
tracings) that statistically meaningful quantitative fate mapping
was unfeasible. Importantly, for all tracings, we found that the
ratio of α- to β-cells within clones at P14 matched the global ratio
within islets, as assessed by volumetric analysis (estimated at
around 1:2, Fig. 4e, Supplementary Fig. 3a and “Methods”),
confirming the representativeness of the induced population.
(Note that the proportion of β-cells within islet clones continued
to increase during the later stages of postnatal growth.) Since, at
the E12.5 induction time, 48% of islet cell-containing clones were
bipotent, containing both α- and β-cells (Fig. 4f), it followed that
sublineage restriction is not fully resolved by this stage. (Note
that, here, and in the remainder of this section, we reserve the
term bipotent to refer to the presence of both α- and β-cell
sublineages in individual clones. Moreover, proliferative cells
that are restricted to either the α- or β-cell sublineages are
referred to as “precursors”, reserving “progenitor” for cells
that are bipotent, capable of contributing both ductal and islet
cells, or α- and β-cells.)
To interpret the compositional data, we first reasoned that, if
the higher proportions of β-cells were due to enhanced
proliferation of β-cell precursors, then unipotent β-cell clones
should be larger than unipotent α-cell clones. However, both
showed the same average size (Supplementary Fig. 3b), arguing
against differences in the division rate between sublineages.
Instead, this finding suggested that the bias towards β-cell fate
arises from more frequent commitment of progenitors into the β-
cell sublineage, with β-cell precursors having the same subsequent
rate of proliferation as α-cell precursors. We note that differences
in division rate would also be manifest in other signatures, such as
non-exponential clone size dependencies (see “Methods” Alter-
native models and parameter-fitting and Supplementary Fig. 3).
In further support of this conclusion, we found that unipotent β-
cell clones were around twice as abundant as α-cell clones on
average (Fig. 4f) across all tracings, confirming that the bias in
islet composition reflects a persistent differentiation bias of
bipotent progenitors towards the β-cell lineage.
We then questioned the relative timing of α/β-cell fate
acquisition, turning to a modelling-based approach to analyse
the data. Specifically, we proposed that fate restriction into the
two main sublineages (α- and β-cell) occurs after n rounds of
division following the initial commitment of progenitors into the
endocrine lineage, with the particular sublineage allocated
stochastically according to the measured α- to β-cell ratio
(Fig. 4e). (Note that a small degree of cell-to-cell variability in
n around the average would not change results significantly.)
Based on this minimal model (see Fig. 4g for a typical
simulation), we sought to determine n reasoning that, if n were
small, meaning that sublineage restriction occurred soon after
endocrine commitment, one would observe a predominance of
unipotent clones, while if n were comparable to N, the total
number of divisions over the time course, one would observe a
high degree of bipotency (Supplementary Fig. 3c). Based on this
model, from the average total size of islet clones traced between
E12.5 and P14, we inferred some N= 2.6 divisions. Then, from a
fit to the measured frequencies of unipotent and bipotent clones
(Fig. 4f), we obtained an estimate of n= 1.7 ± 0.4 divisions
(Supplementary Fig. 3c and “Methods”: Alternative models and
parameter-fitting).
Based on these estimates, we found that the model could
predict quantitatively the exponential dependence of the marginal
distribution of islet clone size (Fig. 4h), i.e. the distribution of α-
cell clone size independent of β-cell number and vice versa.
Furthermore, the model predicted correctly that the global α- to
β-cell ratio seen in the overall tissue should be observed both in
the respective unipotent clone numbers, and in the ratio of α- to
β-cells within bipotent clones (Supplementary Fig. 3a). Incorpor-
ating small levels of apoptosis in the model did not give rise to
markedly different joint clone size distributions (Supplementary
Fig. 3l), while based on Caspase 3 expression, apoptosis in
pancreas appeared to be minimal at E14.5, E15.5 and E18.5
(Supplementary Fig. 3n–p). Finally, we found that the model
could predict accurately the joint distribution of α- and β-cell
clone size (Fig. 4i).
As defined, the model predicts only the effective timing of fate
transitions based on the number of rounds of division following
commitment to the endocrine lineage. Based on average clone
sizes from the E12.5, E15.5 and E18.5 tracings (Fig. 4h–k,
Supplementary Figs. 4 and 5a–d), conversion of this estimate into
a time-scale suggests that the bulk of commitment of bipotent
progenitors from the E12.5 induction occurs around E15 and lasts
until E18 (“Methods”, Alternative models and parameter-fitting).
Consistent with this reasoning, a detailed fate mapping over these
time windows (Fig. 4j–n, Supplementary Figs. 4a–f and 5a–i)
confirmed a drastic reduction in the frequency of bipotent islet
clones from the E15.5–P14 tracing (18%), with this fraction
becoming even smaller in the E18.5–P14 tracing (<10%) (Fig. 4f,
n). Importantly, using parameters obtained from the modelling of
the E12.5–P14 data, we found that the model provided a
consistently good fit across the range of metrics above at all
timepoints (Fig. 4j–m and Supplementary Fig. 5a–e, g, h).
These results were supported by additional short-term tracings,
which showed that few clones traced between E12.5 and E14.5
had already up-regulated markers of endocrine fate, with a
gradual increase of insulin+ or glucagon+ cells in clones traced
from E12.5 to E15.5, and E12.5 to E18.5 (Fig. 4o and
Supplementary Fig. 2l–r). Concentrating on clones containing
primitive ductal epithelium (PDE) and/or islet components, E14.5
clones were overwhelmingly of PDE origin, with a gradual
increase in the frequency of unipotent islet clones and PDE–islet
clones at E15.5 and E18.5 (Supplementary Fig. 2l–r), consistent
with the progressive specification of PDE cells into either of the
islet sublineages during PDE clone expansion. From the analysis
of clones traced from E12.5 to E14.5, E12.5 to E15.5 and E12.5 to
E18.5, combined with insulin/DBA and glucagon/DBA immu-
nostaining, we did not observe insulin+ or glucagon+ cell-
contributing clones in PDE or ducts (Supplementary Fig. 2l–r),
although PDE localisation and endocrine lineage segregation
might be temporally correlated33).
To further study the spatial location of early endocrine
progenitors and their progenies, we stained embryonic tissue
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Fig. 4 Islet cells originate from bipotent islet progenitors that become sublineage-restricted. a Experimental schedule. Representative images from 4
experiments of b bipotent, c unipotent β-cell, and d unipotent α-cell clone (based on >60, 45, >20 recorded images, respectively). Insulin is grey, glucagon
is pink. Arrows (arrowheads) indicate insulin+ (glucagon+) cells. e Fraction of β-cells (normalised to α+β-cell number) at P14 in islets (n= 36 islets from
N= 4 mice) and clones traced from E12.5 to P14 (n= 138 clones from N= 4 mice; mouse with low ratio contained only 7 clones), quantified volumetrically
from 100 μm section. Error bars show average ± SD. f Percentage of clone types (n= 138 clones from N= 4 mice). Error bars show average ± SEM.
g Typical model lineage (“Methods”): following endocrine commitment, progenitors undergo average of n rounds of stochastic division after which they
become sublineage-restricted choosing randomly between α- or β-cell fate in ratio 1:2 (cf. “loaded dice”). Between E12.5 and P14, islet progenitors and
progeny undergo average of N rounds of division. For simplicity, model excludes differentiation into minority sublineages. h Cumulative size distribution of
islet clones traced from E12.5 to P14 disaggregated by composition (total black, α-cell purple and β-cell blue). Data shown as dots (n= 138 clones from
N= 4 mice, error bars show average ± SD) and fitted model predictions as lines. i Joint distribution of α- and β-cell numbers in islet clones from E12.5 to
P14 tracings from data (left) and model (right) (main text and Methods). Cumulative size distribution of islet clones (key as in h) traced from j E15.5 to P14
(n= 40 clones from N= 3 mice) and k E18.5 to P14 (n= 65 clones from N= 3 mice). Joint distribution of α- vs. β-cell numbers in clones traced from l E15.5
and m E18.5 (cf. model prediction in Supplementary Fig. 5a, b). n Percentage of clone types traced from E15.5 to P14 (n= 40 clones from N= 3 mice) and
E18.5–P14 (n= 65 clones from N= 3 mice). Error bars show average ± SD. o Percentage of clones contributing to insulin+ or glucagon+ lineage from E12.5
to E14.5, E12.5 to E15.5 and E12.5 to E18.5 tracings, co-stained with DBA and glucagon, or DBA and insulin, showing no statistically significant difference for
all timepoints (P > 0.2, Mann–Whitney). n= 105 (104) clones from N= 3 mice for E14.5 insulin/DBA (glcg/DBA) (P= 0.40, two-tailed Mann–Whitney
test). n= 140 (137) clones from N= 5 mice for E15.5 insulin/DBA (glcg/DBA) (P= 0.30, two-tailed Mann–Whitney test). n= 58 (65) clones from N= 3
mice for E18.5 insulin/DBA (glcg/DBA) (P= 0.80, two-tailed Mann–Whitney test). Error bars show average ± SD. Source data provided as Source
Data file.
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for chromogranin A (Chrom A). While at E15.5 Chrom A+ cell
clusters were small and did not present a typical islet shape
(Supplementary Fig. 2g–k), we found that at E18.5 Chrom A+
areas showed a wide range of sizes, with some areas presenting
fully formed islet morphology, while others appeared as very
small clusters (Supplementary Fig. 2g, h). We then turned to the
E12.5–E18.5 tracing. Within the more fully formed islet clusters,
we observed that clones tended to be more fragmented
(Supplementary Fig. 2i), while smaller Chrom A+ clusters were
associated with more cohesive clones at the interface of DBA+
and Chrom A+ cells. Notably, although many cells within clones
were only Chrom. A+ or only DBA+, some were DBA+ Chrom.
A+, suggesting that specification into the endocrine lineage may
occur already in the PDE (Supplementary Fig. 2j, k).
Finally, the ratio of α- to β-cells is known to change during
postnatal growth in a manner consistent with preferential β-cell
proliferation25. To confirm this prediction, we performed
additional tracings from E12.5 to P28 (Supplementary Fig. 5j±o).
The frequency of bipotent islet clones stayed constant compared
to the E12.5–P14 tracing (Supplementary Fig. 5l), consistent with
unipotency during postnatal growth. We found that, in contrast
to the E12.5–P14 tracings, the average β-cell clone size increased
by a factor 2, whereas the α-cell clone size did not change,
consistent with the observed tissue ratios (Supplementary
Fig. 5k–o). This argued that the expansion of the β-cell
compartment post-P14 is driven by enhanced β-cell renewal,
which comprises a single equipotent population of precursors, as
evidenced again by the exponential dependence of the clone size
distribution (Supplementary Fig. 5m).
Importantly, in contradiction with existing hypotheses14,20,32,
our findings showed that a rigid temporal sequence of islet cell
sublineage restriction (α-cell production occurring substantially in
advance of β-cell production) was not compatible with the data: If
restriction to the α-cell lineage occurred early in development
(around E10) while β-cells emerged after E13, one would predict
almost pure unipotency of islet clones, a behaviour ruled out by
the data (cf. Fig. 4f and Supplementary Fig. 3d, e, g). However, we
could not rule out a modest temporal delay (on the timescale of
the cell cycle) in the appearance of different sublineages, even at
the later stages of embryonic development, leaving open the
possibility that local egression of α-cell restricted precursors from
ducts might precede that of β-cell restricted precursors17 (see
“Discussion”). However, from short-term tracings, E12.5–E14.5,
E12.5–E15.5 and E12.5–E18.5, clones analysed at E14.5, E15.5 and
E18.5 showed no statistically significant difference in the
contribution to insulin+ and glucagon+ cells (Fig. 4o, P > 0.2 at
all timepoints, Mann–Whitney).
Lineage tracing of Ngn3-expressing progenitors. Finally, to
further challenge our findings, we turned to a targeted lineage
tracing strategy, using a Ngn3-CreER™;CAG-CAT-EGFP reporter
mouse model to mark Ngn3+ cells34–36. To track potential
changes in fate bias at the tissue level, mice were non-clonally
induced at E12.5 or E15.5 and tissue fixed at P14 (Fig. 5a and
Supplementary Fig. 4g, h). Consistent with Ngn3 being a marker
of endocrine commitment, lineage labelled cells were restricted to
islets (Fig. 5b–e). To quantify the composition of labelled cells,
thin tissue sections were immunostained for glucagon and insulin
to determine the labelled α- and β-cell fractions benchmarked
against the composition of the total islet population (Fig. 5b–e).
Notably, comparison of labelled cells with the tissue average
showed no statistically significant difference at both induction
times (Fig. 5c). Although these findings do not support a fate bias
during the later stages of embryonic development30, they corro-
borate our findings based on the unbiased R26-CreERT2/R26R-
Confetti tracings that, at these induction times, sublineage
restriction into the α- or β-cell sublineage occurs in a largely
contemporary manner.
Discussion
Using a combination of clonal lineage tracing and biophysical
modelling, we have traced the cellular dynamics of islet specifi-
cation during embryonic and early postnatal development in
mouse. These results showed that, following commitment to the
endocrine lineage, islet progenitors produced at E12.5 or later
amplify through an average of 2–3 rounds of symmetric cell
division before becoming sublineage restricted, choosing sto-
chastically between α- or β-cell fates in the ratio of around 1:2
(Fig. 5f). Whether stochastic cell fate allocation follows from an
intrinsic cell-autonomous programme or is mediated by signals
from neighbouring cells remains an important question for future
studies.
In the course of islet development, endocrine progenitors
egress from ducts forming nascent islets that progressively coa-
lesce into compound polyclonal structures16 that become further
dispersed during islet growth, before undergoing a low rate of
fission during postnatal growth. Such behaviour is in line with the
findings of a recent study showing that islet progenitor egression
from ducts involves a highly local process17. This combination of
progenitor coalescence, stochastic amplification and subsequent
islet fission, leads to the emergence of an exponential-like dis-
tribution of islet sizes. Interestingly, a similar exponential-like
distribution is found in human with comparable mean islet size,
suggesting that the mechanism of size regulation may be
conserved18.
Previously, it has been hypothesised that endocrine cell genera-
tion occurs in a step-wise, although partially overlapping,
fashion14,17,20,32. However, consistent with the results of unbiased
lineage tracing, our targeted lineage tracing studies based on the
Ngn3 promoter (both from E12.5 and E15.5) showed no evidence of
strong temporal sequencing in the respective allocation of α- and β-
cell fate after ~E13.5. Instead, quantitative analysis of the clonal fate
data suggested that, following an early amplification phase, com-
mitment to the α- and β-cell sublineages occurs stochastically in a
near-contemporary manner, with probabilities consistent with the
abundance of cell sub-types. Notably, the use of an unbiased lineage
tracing strategy (based on the R26 promoter) enables the induction
of cells of both high and low Ngn3 levels, unlike the previous lineage
tracing strategies that rely on Ngn3 promoter activity10. Impor-
tantly, while highlighting an initial phase of α-cell specification until
~E14.5, recent studies suggest a subsequent phase of simultaneous
α- and β-cell generation, with cells derived from a common bipo-
tent progenitor17,37,38.
Importantly, a recent study probing this question via single-cell
RNA-sequencing between E13.5 and E15.5 demonstrated that,
although cells expressing α-cell differentiation markers start to
appear around 0.5–1 day earlier than β-cell markers, both cell
types continue to be produced in an exponentially increasing
manner over the next few days, quadrupling each day17 between
E13.5 and E15.5. Such behaviour is consistent with our analysis
as, in an exponential growth regime, the bulk of islet cells would
be produced at the latest stage, effectively dwarfing any small
biases present earlier in development. Whether the hallmark
“mantle-core” structure observed in islets7,17,33 develops through
the sorting of randomly allocated α- and β-cells (which is con-
sistent with the extensive clonal fragmentation we observed in
islets), or whether α-cell restricted precursors egress from ducts
slightly in advance of β-cell restricted precursors is left as a
question for future studies. In summary, our results provide
insight into the functional dynamics of islet fate allocation,
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providing a quantitative platform to study the molecular pro-
grammes that effect the timing of sublineage restriction and the
statistics of individual cell fate choice.
Methods
Experimental model. For the unbiased lineage tracing, R26-CreERT2 and R26R-
Confetti mice (JAX STOCK Gt(ROSA)26Sortm1(CAG-Brainbow2.1)Cle/J)39,40,
were crossed. For lineage tracing of embryonic Ngn3-positive islet progenitor cells,
Ngn3-CreERTM34 males were crossed with CAG-CAT-EGFP36 females. All mice
were of C57BL/6J background.
Animals of mixed gender were used; littermates were housed together and
tissues were collected before weaning. Mice were kept at ambient temperature of
19–23 °C, humidity of 45–65%, and 12 h light/12 h dark cycle. This research has
been regulated under the Animals (Scientific Procedures) Act 1986 Amendment
Regulations 2012 following ethical review by the University of Cambridge Animal
Welfare and Ethical Review Body (AWERB) for R26-CreERT2 lineage tracing; and
the approval of the Institutional Animal Care and Use Committee of National
Institutes of Natural Sciences, Japan, for Ngn3-CreERTM lineage tracing.
Induction of lineage tracing. Tamoxifen (Sigma, T5648-1G) was prepared at
10 mg/ml in corn oil (Sigma, C8267) for R26-CreERT2 inductions; mice were
intraperitoneally injected with Tamoxifen at 0.020 and 0.025 mg per gram of
pregnant female for the E9.5 and E12.5 tracings, respectively, and 0.01 mg for E15.5
and E18.5 induction. Pancreas from E14.5, E15.5, E18.5. P14 or P28 neonatal pups
was collected. Part of our current data set is based on tissue harvested in an earlier
study6, but not detailed or analysed there or elsewhere. For Ngn3-CreERTM tracing,
4.0 mg of Tamoxifen (Toronto Research Chemicals), solubilized in 100 μl Peanut
oil (Sigma-Aldrich) was administered orally into pregnant females once at E10,
E12.5 or E15.5. Pups were delivered by Caesarean section at E19.5 (considered as
P0) and fed by foster mother. Pancreas from P14 pups were harvested for analysis.
For both lineage tracings, pups from mothers without TAM administration were
used as a control (ref. 6 and Supplementary Fig. 4a, b), whereby male and females
of identical genotype as the experimental one were mated. Noon of the day of plug
was regarded as E0.5.
Tissue preparation. Embryonic and neonatal pancreas was fixed in 4% Paraf-
ormaldehyde from 45min to overnight, dependent on its developmental stage, and
then washed in phosphate-buffered saline (PBS) extensively. For cryostat sec-
tioning, samples were incubated in 30% sucrose overnight, mounted in OCT and
subsequently 100 μm cryostat sectioned as in Figs. 1–4, or 7 μm cryostat sectioned
as in Fig. 5.
Tissue staining. Thick 100 μm cryostat sections were rehydrated in PBS. Sections
and whole mount pancreata were blocked overnight in PBS, 2% donkey serum and
0.5% Triton-100X. The samples were incubated in primary antibodies (Chromo-
granin A, 1:180 from Abcam, ab15160; insulin, 1:100, from Abcam, ab7842; glu-
cagon 1:200, from Abcam, ab10988); and Dolichos biflorus agglutinin (DBA)
biotinylated (1:270, from Vectorlabs, B-1035) for 3 days at 4 °C. Secondary anti-
bodies were applied (from Thermo Fisher Scientific) and AF647-Streptavidin







































































Fig. 5 Lineage tracing using Ngn3 promoter confirms contemporary specification of α and β-cell lineages. a Experimental schedule for Ngn3-CreER
lineage tracing at non-clonal levels of induction. bWide-field section of tissue showing typical labelling efficiency based on 3 experiments (and >10 images)
from E12.5 to P14 tracing with labelled cells marked by GFP. c Quantification of the ratio of glucagon+ to insulin+ cells on thin sections from islets as a
whole and from labelled (GFP+) cells from E12.5 to P14 and E15.5 to P14 tracings (n= 83 and n= 81 islets, respectively, from N= 3 mice). Error bars show
mean ± SD. Representative images of GFP+ cells within islets based on 3 experiments (and >25 images each) traced d from E12.5 to P14 and e from E15.5
to P14. Insulin is red and glucagon is white for (b, d, e). f Summary of the key events in islet formation based on current findings: endocrine progenitor cell
commitment, stochastic progenitor expansion and local egression from ducts, islet sublineage restriction and islet fusion, sublineage expansion and islet
fission, and continuing β-cell sublineage expansion. Source data provided as Source Data file.
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Biolegend, 405233) for 2 days at 4°C. All tissues were cleared with RapiClear 1.52
(from SunJin Lab, RC152001).
Thin sections were incubated in 2% Serum, 0.1% Triton-100X in PBS for
30 min, subsequently incubated in primary antibody in 0.01% Triton-100X in PBS
overnight (insulin 1:100, from Abcam, ab7842, glucagon 1:200 from Abcam,
ab10988, cleaved caspase 3, 1:400, from Cell Signalling, 9664S), washed 3 times for
10 min the next day, and incubated with secondary antibody in 0.01% Triton-100X
for 3 h, washed and mounted.
Confocal microscopy and image analysis. Images of thick section pancreas were
acquired using a Leica TCS SP5 confocal microscope for R26-CreERT2/R26R-
Confetti analysis of Chromogranin A and DBA staining, and for the insulin glu-
cagon analysis of Ngn3-CreERTM; CAG-CAT-EGFP. For the analysis of insulin and
glucagon staining of R26-CreERT2/R26R-Confetti samples, a Zeiss 880 microscope,
with the spectral imaging module, was used. For both microscope models, the tiling
modules were applied to record the large-scale events. To obtain 3D reconstructed
images from Z stacks from an image captured by the Leica SP5 microscope, Imaris
software (v8, Bitplane) was used, and numbers of insulin+ and glucagon+ cells
were counted in the slice mode. Volumes of objects such as ducts and islets were
recorded with Volocity (6.5) software. We estimated the average volume of a cell to
be around 300 μm3 based on the measurement of single cell clones. By setting
intensity thresholds manually for every image, clusters of different confetti colour
were identified, and the required parameters computed by the software. Infor-
mation about the constituent cell types within clusters was collected by analysing
co-localisation of clusters with a pancreatic marker in the Z-layer mode of Volocity.
Cell fate assessment. All analyses were performed on high resolution images. Fate
assignment was based on DAPI, DBA, Chromogranin A insulin and glucagon
staining. For the assessment of clonality with statistical confidence, the four-colour
confetti reporter system was used in the R26-CreERT2/R26R-Confetti analysis. As a
result, it was necessary to image Chromogranin A and DBA in the same colour
channel. However, the respective cell types could be distinguished reliably by
morphology and distinct intensity of the staining6. Ductal structures were recon-
structed using defined threshold of staining intensity.
Quantification and statistical analysis—statistical inference of clonality. To
test for clonality in the tracing data, we first counted all unlabelled islets across the
ensemble of pancreatic thick sections, as well as the number of confetti colours in
the islets that were labelled. We found consistently that, both for the E9.5 and E12.5
tracings, the majority of islets were fully unlabelled, while the large majority of
labelled islets contained marked cells bearing only a single confetti colour (Sup-
plementary Fig. 1h). These results were consistent with a pattern of stochastic and
infrequent cell induction. To be confident in the degree of clonality of labelled cell
clusters in islets, it was necessary to test statistically that the observed bipotency of
islet sublineages was not artificial, arising from the chance induction of two
independent unipotent clones of the same confetti colour ending up in the same
islet, and being mis-assigned as bipotent. In the simplest null model, where all
clones were derived from unipotent progenitors (in the ratio 1/3 α-cells and 2/3 β-
cells), and the colour distribution were 25% GFP, 25% RFP, 25% CFP and 25%
YFP, there would be four scenarios in which a GFP+ clone could be in the same
islet as another clone: In three cases, this would be with a clone of another confetti
colour, and in one case it would be with another GFP+ clone. Thus, the probability
of two GFP+ clones being found in the same labelled islet (and therefore not
distinguishable) is one-third of the probability of finding a GFP+ clone and
another differently coloured clone to be in the same islet. In our case, the latter is
found to be around p2col= 25% at E12.5. Moreover, in the unipotent null model,
these two GFP+ clones have three possible compositions: Either they are both
derived from unipotent α-cell clones (prob. 1/9), both from unipotent β-cell clones
(prob. 4/9) or arising from different sublineages (prob. 4/9). Thus, the probability
of “fake bipotency” would be 4/9*1/3*p_2col (i.e. around 4%). Modifying this
simple argument to take into account the observed mosaicism (11% GFP, 39%
RFP, 4% CFP and 46% YFP at E9.5; 17% GFP, 38% RFP, 17% CFP and 28% YFP at
E12.5), one can estimate numerically the probability for double-labelling to occur
in a given islet of cells bearing the same confetti colour. Although this probability is
then colour-dependent (and highest for RFP/YFP), numerical simulations of sto-
chastic induction according to the balance of colour probability above allowed us to
infer that 91% of islet clusters bearing a common colour on average should be of
clonal in origin (with different colours having different frequencies, and thus dif-
ferent threshold of confidence in clonality). From this data, we could thus estimate
with high precision the average fraction of a given islet labelled by a clone (and thus
the effective number of progenitors that found a given islet, see Fig. 2n).
When performing quantitative analysis of the lineage tracing data, we also kept
track of adjacent islets labelled by the same confetti colour (which could be safely
estimated as clonal given the low-labelling density). Importantly, the frequency of
such clones spanning different islets was also small (8 out of 55) from the E12.5
tracings, consistent with a relatively low fission rate between E12.5 and P14.
To summarise, the initial E12.5 tracing data (Figs. 1 and 2) thus consisted of 69
clonal fragments in isolated islets (from which we extract 69 islet size to clone
cluster size ratios, Fig. 2k, l), localised in 51 islets (with some islets containing more
than one colour). We obtained 55 reconstructed islet clones when grouping clonal
fragments in nearby islets, which we then correlated with the ductal compartment
size. In the E9.5 tracing, clones were found to span neighbouring islets more
frequently (18 out of 48), consistent with the earlier labelling of multipotent ductal/
islet progenitors seeding independently several nearby islets. In total, the initial
E9.5 dataset (Figs. 1 and 2) thus consisted of 93 clonal fragments, localised in 73
islets, and we obtained 48 reconstructed clones when grouping clonal fragments in
nearby islets.
To assess the potency of islets clones, tracings were repeated and tissue stained
for insulin and glucagon expression. To assess whether islet doublets were
associated with fission or fusion events, we measured the localisation of clones of a
given colour within a doublet, reasoning that fission should result in only a single
side being labelled, while fusion should result in both sides containing labelled cells.
We restricted the analysis to large clones—comprised of more than n > 5 cells—in
order to assess with high confidence whether an islet doublet containing cells on
only one side was not due to fission and stochastic positioning of all cells on one
side, which has an estimated probability (1/2)n−1, where n is the cell number. We
note that the analysis of fission and fusion relies on the assumption that clones
fragment within islets so that their position is chosen at random and that they can
be segregated in two sides upon fission. This behaviour was corroborated by
detailed analysis of the clonal data, which showed that the 55 clones traced from
E12.5 to P14 were partitioned into some 284 fragments, translating to over 5
fragments per clone. Interestingly, plotting the fragment size distribution of islet
clones revealed an extremely good fit to a log-normal distribution, as expected from
a recent model of stochastic clone fragmentation41 (Supplementary Fig. 1m).
Finally, to assess the overall proportion of β-cells as a fraction of total islet cell
number (taken as the sum of α- and β-cells), we measured n= 36 islets in N= 4
mice at P14 (the same time point used for the clonal tracing from E12.5 to P14),
and calculated in each islet the total β-cell volume and α+ β-cell volume. This led
to a fraction of 0.68 of β-cells over the entire datasets. Applying the same analysis
to the clonal data we obtained an overall fraction of 0.66. From this value, we
concluded in the main text that the ratio of α:β cells at P14 is approximately 1:2.
We also averaged each volume fraction of β-cells over each mouse to display
variability as seen in Fig. 4e, Supplementary Figs. 3a and 5f.
Quantification and statistical analysis—theoretical basis for interpreting
lineage tracing data. The theoretical basis of clonal lineage tracing has been
studied extensively (see, for example, ref. 23). In particular, it has been shown that
hallmarks of cell fate behaviour can be found in the statistical behaviour of the
clone size distribution. Clones derived from a single equipotent population of
progenitors that divide stochastically give rise to a size distribution in which the
probability of finding a clone of size n is given by the scaling form,
Pn tð Þ ¼ 1n tð Þ f nn tð Þ
 
, where n(t) denotes the average clone size. In the case of sto-
chastic birth or birth-death processes, or in extrinsic neighbour-based loss/repla-
cements in two dimensions or higher, the scaling function has a simple exponential
dependence, f xð Þ ¼ exp xð Þ. As discussed in the main text, the cumulative islet
clone size distribution obtained from the E12.5 to P14 tracing also adopts a
strikingly exponential size dependence, both when examining the overall clone size,
or clone sizes of the separate α- and β-cell compartments. (In line with standards
adopted in the literature42, we counted n > 100 clones from N= 4 mice in order to
provide enough statistical power to reach this conclusion with statistical con-
fidence. Specifically, exponentiality of the distributions were tested via a
Kolmogorov–Smirnoff test with Lilliefors correction, and revealed no statistically
significant difference for either of the E12.5 tracings—Fig. 2h and Fig. 4h—even at
the P= 0.2 confidence threshold.) This is in stark contrast to that found for the
E12.5–P14 ductal and acinar clone sizes obtained from the same lineage tracing
strategy6; these distributions displayed very broad tails, consistent with a model of
ductal termini-driven branching morphogenesis based on a branching-annihilating
random walk6,43. Similarly, we note that the analysis of neocortical development in
mice shows a markedly different, Gaussian-like, distribution of clone size (indi-
cative of more deterministic processes), despite average clone sizes being similar to
that observed in the current system, arguing that such lineage tracing experiments
can distinguish between hypotheses44. The collapse of the islet clone size dis-
tribution onto an exponential scaling form suggested that islet progenitors function
as an equipotent population, driving islet expansion through rounds of stochastic
cell division—a simple birth process (see below for detailed parameter fitting). Note
that total clone sizes cannot reach zero in these experiments (as this corresponds to
complete clonal loss, which is obviously not detectable in a lineage tracing assay
based on the analysis of fixed samples), although unipotent clones contain, by
definition, zero cells of one type.
To take into account sublineage segregation within the islet compartment, we
considered a minimal extension of the model in which endocrine progenitors
transit irreversibly from a bipotent phase (capable of generating both α- and β-
cells) to a unipotent phase in which the resulting precursors become irreversibly
restricted to either the α- or β-cell sublineages. (For simplicity, we neglected other
islet lineages whose abundance was below the threshold to achieve a statistically
significant analysis.) More specifically, we considered a model in which progenitors
P, divide symmetrically,
● P→ P+ P at rate λ(t)
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and transit stochastically and irreversibly into precursors A or B committed to the
α- or β-cell sublineages, respectively,
● P→ A at rate kA(t)
● P→ B at rate kB(t)
Each unipotent precursor A and B is also able to duplicate at rates λA(t) and
λB(t), respectively, which could in principle be different from λ(t). Further, all of
these rates could, in principle, vary over time. For instance, the prevailing model of
sequential α and β-cell production would translate to a rate kA(t) rapidly increasing
during early pancreatic development (E9.5–E12.5), while kB(t) only starts
increasing from zero later on in development (E12.5–E15.5). It has also been shown
that the ductal plexus provides a niche for islet cell production until late
embryogenesis; so one may expect that the phase of P cell production may also be
long-lived, with proliferation (at rate λ(t)) being overtaken by differentiation into A
and B precursors taking place only late in embryogenesis. To circumvent such
uncertainties, in fitting the clonal data, we refer to the effective number of divisions
performed between different points of the lineage tracing, without having to
reference the timings of proliferative expansion.
Quantification and statistical analysis—alternative models and parameter-
fitting. To fit the model to the experimental data, we constructed distributions of
clone size and composition numerically using stochastic simulations of at least
10,000 clones, each derived from a single bipotent progenitor cell labelled at the
initial time point. We made use of standard bootstrapping methods on the lineage
tracing data to build standard deviations, as well as 95% confidence intervals for
our predictions. To constrain and test the model, we focussed on the E12.5–P14
R26-CreERT2/R26R-Confetti tracings, for which the largest data set was available,
and where islet clones were resolved with high statistical confidence. However, to
further challenge the model, we used the fits to predict clone size and composi-
tional dependences using the E15.5–P14 and E18.5–P14 R26-CreERT2/R26R-
Confetti tracings, as well as the population-level Ngn3-CreERTM tracings. To fur-
ther constrain the model, we made use of several robust features of the data:
First, we noted that the overall α- and β-cell distributions were well-described
by a simple exponential size dependence (Fig. 4h, j, k and Supplementary Fig. 5m)
(as was the overall clone size distribution), and that α- and β-cell unipotent clones
also had similar sizes (Supplementary Fig. 5k). This is not what one would expect
in models where the division rate of β-cells would be much larger than α-cells,
suggesting that λA(t) ≈ λB(t). Simulating very different proliferation rates for α- and
β-cells produced a marked departure from exponentiality (see Supplementary
Fig. 3k, where n/N= 0.333 and λA= 4λb). Indeed, the higher abundance of β-cells
over α-cells overall could be explained by the production of a larger number of
unipotent β-cell clones as compared to unipotent α-cell clones, and larger numbers
of β-cells in bipotent clones (Fig. 4f and Supplementary Fig. 3a, b). This situation
prevailed in all tracings, confirming that differences in α- and β-cell production was
not due to temporal differences in differentiation rates. This argues that that the
rate of transition into the β-cell sublineage is larger than into the α-cell sublineage,
kB > kA. This observation was further confirmed by the E12.5–P28 tracing
(Supplementary Fig. 5j–o), where the phenomenology was reversed: α-cell clones
had not increased in size since P14, while β-cell clones had more than doubled in
size, resulting in exponential distributions with different slopes. This was indicative
of a difference in the division rates, λA(t) < λB(t), appearing between P14 and P28,
i.e. that the expansion post-P14 of the β-cell compartment becomes driven by
preferential proliferation, and not preferential differentiation of bipotent
progenitors P into β-cell precursors B, as earlier on. Here, we note that we are able
only to refer to effective proliferation rates: If, for example, there were an
undisclosed residual base-line rate of cell apoptosis, numerical simulations shows
that the join clone size distribution would be largely unaffected (Supplementary
Fig. 3l), while the true proliferation rate would be proportionately higher than the
inferred effective rate to accommodate the apoptosis rate.
Second, as time is counted here in terms of numbers of divisions, the relative
division rate of the bipotent progenitor population is irrelevant and, for simplicity,
can be set equal to that of unipotent precursors, and taken as constant: λ ≈ λA ≈ λB
(with the total number of divisions and timing of commitment/differentiation
being the only relevant quantity).
Third, as mentioned above, if bipotent progenitors and unipotent precursors
coexisted in the long term and had highly different dynamics (for instance in their
division rate), one would expect to see more complex clone size distributions,
which is ruled out by the simple exponential scaling form for all time points. To
show this, given that roughly one half of the clones traced from E12.5 displayed
bipotent outcomes, we simulated a scenario in which 50% of induced clones were
unipotent precursors (either α- or β-cell lineage in a 1:2 ratio), and 50% were
bipotent until the end of the tracing. However, if both populations had the same
division rate, a fraction of clones derived from bipotent progenitors would still end
up with unipotent output due to chance and small number statistics (for instance, a
two-cell clone make derive from the stochastic specification of β-cells), and the
overall bipotency fractions would be too low to infer bipotency with confidence.
The only solution to remedy this is to assume a much larger proliferation rate of
bipotent progenitors (so that their clone size is so large as to make chance
unipotent outcomes unlikely), while maintaining the overall average clone size of
5.6 cells. We thus simulated stochastic unipotent precursors undergoing N= 0.75
divisions and stochastic bipotent progenitors undergoing N= 3.25 divisions.
However, this resulted in non-exponential clone size distributions, which despite
the higher number of fitting parameters compared to our previous simpler model,
worsened the fit in particular for the total clone size (Supplementary Fig. 3m).
Thus, the simplest model, consistent with the qualitative features described
above (from E12.5 to P14) is one where (i) division rates are constant, and (ii) a
transition takes place from bipotency to unipotency (viz. rates kA(t)= kB(t)= 0 for
t < n/N, and kA(t)= KA and kB(t)= KB= 1− KA for t > n/N, with constant
probabilities KA (and therefore KB) chosen to match the proportions of α-cells and
β-cells found in the organ overall.
From a more quantitative standpoint, the simplest model thus relies on three
key parameters: the relative probability to differentiate into α- vs. β-cell fate, kA, the
total number of cell divisions between E12.5 and P14,N, and the timing of the
transition n/N (expressed as a fraction of N). The first and second parameters can
be estimated with high precision directly from the data simply by (i) calculating the
total ratio of α to β-cells, which leads to the estimate KA ¼ 0:37 ¼ 1 KB , and (ii)
using the average clone size of 6.1 ± 0.6 cells to estimate N= 2.6 ± 0.1 (mean ±
SEM). The third parameter needs to be fit via numerical simulations of the model.
To constrain the model with the smallest fraction of data (in order to test for
consistency on the remainder of the clonal data), we thus resorted to a simple fit of
the fraction of bipotent clones (which increases monotonically with the timing of
commitment, n/N). We performed 1000 iterations of the numerical simulation,
each time boot-strapping the experimental dataset (to calculate the confidence
intervals on bipotency fraction), and found the best fit for n/N (each time
simulating 10,000 clones). This allowed us to find a best fit and construct a 95%
confidence interval with n/N= 65% ± 15%.
With this best-fit value, several aspects of the data, not used in the fitting
procedure, can be predicted quantitatively by the model, including the joint clone
size distributions of α and β-cell compartments (Fig. 4i). Features of this two-
dimensional distribution include: (i) the exponential-like clone size distributions of
α- and β-cell compartments (Fig. 4h); (ii) the relative fraction of unipotent α- and
β-cell clones (Fig. 4f); (iii) the fact that α- to β-cell ratio is identical when looking
either at bipotent clones only or α/β-cell unipotent clones only (Supplementary
Fig. 3a); and iv) the correlation and variance of α vs. β-cell number in a clone
(Supplementary Fig. 3d, f), showing that the variance increases with the number of
cells in a clone, as expected for a binomial distribution arising from random fate
assignment between α- and β-cell fate. However, we note that the E12.5–P14
tracing data contained 6 clones (out of 138), which were manifest outliers
compared to the model and the rest of the data. These 6 clones all had an average
clone size between 3 and 5 standard deviations away from the mean. To improve
visual comparison between joint distributions of α- and β-cells, we thus “zoomed
in” (in Fig. 4i, compared to Supplementary Fig. 3d) on smaller clones sizes to
concentrate on the bulk of the data. Interestingly, despite their size, these outlier
clones were “normal” in their ratio of α- and β-cells (i.e. an approximate ratio of
1:2, Supplementary Fig. 3d). Given that we did not find these clones to correlate
with areas of larger clonal induction, we reasoned that they were unlikely to arise
from fusion events, and might thus arise due to rare hotspots of proliferation
during early embryogenesis. This would be consistent with the fact that such
outliers were not present in the E15.5 or E18.5 tracings.
To perform a sensitivity analysis, the predictions were contrasted with a model
involving earlier sublineage commitment (i.e. mostly unipotent α- and β-cell clones
being present, and thus with highly independent α- vs. β-cell compartment sizes, see
Supplementary Fig. 3g), or later sublineage commitment (where α- and β-cell
compartment size in a clone are maximally correlated, as both derive from the same
bipotent progenitor pool, see Supplementary Fig. 3h). Notably, we found an
intermediate level of positive correlation between α- and β-cell numbers in E12.5
clones (slope 0.3 ± 0.04, R2= 0.27), in quantitative agreement once again with the
predictions of the model (Fig. 4i and Supplementary Fig. 3d, i). Alternative models,
such as one where a bipotent islet progenitor self-renews while continuously
producing unipotent α- and β-cells with stochastic fate allocation, provided poor fits
to the data (Supplementary Fig. 3j), including the average and variance of the number
of α-cells in clones with a given number of β-cells (Supplementary Fig. 3d, f)
Although our data ruled out distinct phases of α- and β-cell allocation (a feature
confirmed by the Ngn3-CreERTM tracing), one can, of course, introduce additional
refinements of the minimal model incorporating, for instance, a defined time for
the fate specification of α- and β-cells, as well as small time delays between the
allocation of both. Although these additional parameters only improve marginally
the quality of the fits, the data can accommodate, for instance, a phase of α-cell
allocation (initiating at around TA ≈ 50%) and β-cell allocation (starting later at
around TB ≈ 65%). Note that these delays are within the confidence intervals of n/N
from the minimal model, and that the model still requires the late specification of
α-cells (50% corresponds to around E15.5–E18.5 in embryonic time from the clone
size of the different tracings) compared to past proposals in the literature. Finally,
the same model as for the E12.5–P14 tracing could explain faithfully the E12.5–P28
tracing (Supplementary Fig. 5j–o) by simply assuming that α-cells do not
proliferate within the later time interval (P14–P28), while β-cells undergo an
additional round of division. This is consistent with clone sizes of each
compartment (Supplementary Fig. 5k), as well as overall clonal potency
(Supplementary Fig. 5l), the α- and β-cell clone size distributions (Supplementary
Fig. 5m), and the joint probability distributions (Supplementary Fig. 5n, o).
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Quantification and statistical analysis—number of progenitors per islet.
Finally, our model of clonal dynamics allowed us to infer the mechanisms driving
the heterogeneity in islet size itself. From a theoretical perspective, part of this
heterogeneity could arise from stochasticity in clonal behaviour. However, given
that around 30 progenitors at E12.5 contribute to a given islet, such a “clonal”
source of heterogeneity would be small (i.e. the variance from adding 30 Poissonian





np  32), compared to the wide, experimentally
observed, distribution of islet sizes. We typically found that the variance in islet
volume was close to its average, consistent with the wide distributions previously
measured in the literature18. Although we could find small correlations between
islet size and position towards the centre of the pancreas, islet clone size did
not correlate with position. Having ruled out other factors, such as enhanced
proliferation of all clones in bigger islets, this allowed us to conclude that the bulk
of islet size variance must originate instead from the variability in the number of
progenitors making up an islet (which depends both on the kinetics of islet
aggregation and subsequent fission dynamics). We note however we cannot
exclude within the resolution of the data some spatial variations to the model
parameters, such as specification timing or islet size, which could cause additional
variability in islet size.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The authors declare that all data supporting the findings of this study are available within
the article and its supplementary information files or from the corresponding authors
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